Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.49B
Enterprise Value6.15B
P/E Ratio29.14
PEG Ratio-0.55
Price/Sales Ratio0.67
Price/Book Ratio1.02
Enterprise/Revenue1.26
Enterprise/EBITDA11.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue4.19B
Revenue/Share15.95
Gross Profit629.45M
EBITDA619.56M
Net Income200.3M
Diluted EPS0.66

Balance Sheet

Total Cash1.52B
Total Cash/Share5.04
Total Debt3.83B
Total Debt/Equity1.2
Current Ratio1.36
Book Value Per Share11.08

Price History

52-Week Change-43.85
52-Week High20.2
52-Week Low9.97
Moving Average 50 Days10.97
Moving Average 200 Days14.69

Statistics

Average Volume7.62M
Shares Outstanding298.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.64
Payout Ratio0.2
Last Split Factor13:10
Last Split DateMay 28, 2024
AD